Cardiovascular Health: Longevity through Heart-Healthy Living | NHLBI, NIH Skip to main content
Cardiovascular
-
-
Type 2
Cost of cardiovascular disease events in patients with and without type 2 diabetes and factors influencing cost: a retrospective cohort study | BMC Public Health
World Health Organization Factsheet. Cardiovascular diseases (CVDs). Published 11 June 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 31 August 2023. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, …
-
Diet
Mediterranean and DASH diets may reduce cardiovascular disease risk in adults with type 1 diabetes
by News Sourceby News SourceEating habits aligned with the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet may help lower the risk of cardiovascular disease in adults with type 1 diabetes, …
-
Diabetes Complications
NextGen Precision Health Researchers Discover Potential Treatment for Cardiovascular Complications from Type 2 Diabetes
by News Sourceby News SourceNew research at the Roy Blount NextGen Precision Health Building has uncovered a potential treatment for the underlying cause of cardiovascular disease in people with type 2 diabetes. More than …
-
Type 2
The real-world effect of early insulin therapy on cardiovascular event rates in newly diagnosed type 2 diabetes mellitus
Information source Our data source was a nationwide collaborative network that collected electronic health records of hospitalizations and outpatient care from 19 tertiary-level comprehensive medical centers across China between January …
-
Type 2
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure | Cardiovascular Diabetes
Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on …
-
The authors of a new review paper said that the management of cardiovascular disease is an often overlooked but important aspect of the care of patients with type 1 diabetes. …
-
Type 1
The double burden: type 1 diabetes and heart failure—a comprehensive review | Cardiovascular Diabetology
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7. Article PubMed PubMed Central Google Scholar Mosterd A, Hoes AW. Clinical epidemiology of heart failure. …
-
Type 2
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
by Lee-Ling Limby Lee-Ling LimRawshani, A. et al. Mortality and cardiovascular disease in Type 1 and Type 2 diabetes. Nw Eng. J. Med. 376, 1407–1418 (2017). Article Google Scholar Pearson-Stuttard, J. et al. Trends …
-
Type 2
Statins slightly increase diabetes risk, but cardiovascular benefits remain, study finds
by News Sourceby News SourceIn a recent study published in Lancet Diabetes and Endocrinologyresearchers conducted a meta-analysis of long-term, large-scale, randomized, double-blind controlled trials to determine the effect of statin medication on worsening of …